Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

3.49 

0.06 1.8%

as of Apr 26 '19

52 Week Range:

3.26 19.16


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 11.10
12.23
13.52
14.29
15.37
15.93
15.97
15.70
16.17
16.33
12.72
growth rate 10.2% 10.6% 5.7% 7.6% 3.6% 0.3% -1.7% 3.0% 1.0% -22.1%
Earnings BIT 164.73
188.25
181.61
189.83
183.36
184.99
197.04
227.26
224.27
149.96
109.64
growth rate 14.3% -3.5% 4.5% -3.4% 0.9% 6.5% 15.3% -1.3% -33.1% -26.9%
Avg.PE 15.43
15.38
16.81
15.36
16.45
20.66
33.67
24.19
20.61
12.60
15.62
growth rate -0.3% 9.3% -8.6% 7.1% 25.6% 63.0% -28.2% -14.8% -38.9% 24.0%
ROA 5.67
5.94
6.20
6.11
5.21
4.86
2.61
3.72
3.92
2.35
-12.22
growth rate 4.8% 4.4% -1.5% -14.7% -6.7% -46.3% 42.5% 5.4% -40.1% -100.0%
ROE 14.32
14.35
13.60
12.98
11.45
11.03
6.54
10.33
11.03
7.26
-56.98
growth rate 0.2% -5.2% -4.6% -11.8% -3.7% -40.7% 58.0% 6.8% -34.2% -100.0%
ROIC 10.60
11.13
11.67
10.49
9.34
9.08
4.65
6.48
6.97
4.17
-21.39
growth rate 5.0% 4.9% -10.1% -11.0% -2.8% -48.8% 39.4% 7.6% -40.2% -100.0%
Cur. Ratio 1.97
1.92
2.02
2.08
1.76
1.74
1.86
1.86
1.90
1.67
1.72
growth rate -2.5% 5.2% 3.0% -15.4% -1.1% 6.9% 0.0% 2.2% -12.1% 3.0%
Quick Ratio 0.79
0.85
0.91
0.88
0.70
0.68
0.68
0.70
0.77
0.66
0.63
growth rate 7.6% 7.1% -3.3% -20.5% -2.9% 0.0% 2.9% 10.0% -14.3% -4.6%
Leverage 2.58
2.27
2.12
2.12
2.27
2.27
2.76
2.80
2.83
3.32
7.28
growth rate -12.0% -6.6% 0.0% 7.1% 0.0% 21.6% 1.5% 1.1% 17.3% 119.3%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 0.00
0.00
471.70
506.76
537.34
572.85
626.19
587.94
606.08
758.94
823.42
growth rate 7.4% 6.0% 6.6% 9.3% -6.1% 3.1% 25.2% 8.5%
Acct.Payable 638.76
670.71
708.78
608.85
710.61
750.75
947.57
1,109.59
growth rate 5.0% 5.7% -14.1% 16.7% 5.7% 26.2% 17.1%
Cur.Assets 1,311.80
1,342.10
1,403.80
1,525.83
1,630.24
1,725.93
1,869.90
1,974.70
1,962.04
2,181.91
2,538.58
growth rate 2.3% 4.6% 8.7% 6.8% 5.9% 8.3% 5.6% -0.6% 11.2% 16.4%
Total Assets 1,776.20
1,747.10
1,822.00
1,946.82
2,214.40
2,324.04
2,735.41
2,773.78
2,717.75
3,376.29
3,773.79
growth rate -1.6% 4.3% 6.9% 13.7% 5.0% 17.7% 1.4% -2.0% 24.2% 11.8%
Cash 7.90
96.10
159.20
135.94
97.89
101.91
56.77
161.02
185.49
104.52
103.37
growth rate 1,116.5% 65.7% -14.6% -28.0% 4.1% -44.3% 183.6% 15.2% -43.7% -1.1%
Inventory 679.10
689.90
720.10
806.37
763.76
771.66
872.46
940.78
916.31
990.19
1,290.10
growth rate 1.6% 4.4% 12.0% -5.3% 1.0% 13.1% 7.8% -2.6% 8.1% 30.3%
Cur.Liabilities 667.50
700.10
694.50
732.37
925.64
990.21
966.58
1,063.59
1,034.64
1,309.73
1,472.01
growth rate 4.9% -0.8% 5.5% 26.4% 7.0% -2.4% 10.0% -2.7% 26.6% 12.4%
Liabilities 1,087.10
977.90
964.50
1,028.73
1,241.87
1,300.13
1,744.57
1,781.19
1,757.71
2,360.81
3,255.37
growth rate -10.1% -1.4% 6.7% 20.7% 4.7% 34.2% 2.1% -1.3% 34.3% 37.9%
LT Debt 359.20
208.40
209.10
212.68
215.38
212.79
608.55
568.50
564.58
900.74
1,641.77
growth rate -42.0% 0.3% 1.7% 1.3% -1.2% 186.0% -6.6% -0.7% 59.5% 82.3%
Equity 689.10
769.20
857.50
918.09
972.53
1,023.91
990.84
992.59
960.04
1,015.48
518.42
growth rate 11.6% 11.5% 7.1% 5.9% 5.3% -3.2% 0.2% -3.3% 5.8% -49.0%
Common Shares 62.00
62.00
63.00
63.00
63.00
63.00
62.00
62.00
61.00
60.00
60.00
growth rate 0.0% 1.6% 0.0% 0.0% 0.0% -1.6% 0.0% -1.6% -1.6% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 17.30
15.70
27.30
24.98
9.83
28.12
48.42
20.53
20.30
34.61
44.87
growth rate -9.3% 73.9% -8.5% -60.6% 186.0% 72.2% -57.6% -1.1% 70.5% 29.6%
Cash Dividends 33.00
38.40
44.80
50.91
55.68
60.73
63.10
63.65
63.38
63.15
48.20
growth rate 16.4% 16.7% 13.6% 9.4% 9.1% 3.9% 0.9% -0.4% -0.4% -23.7%
Cash From OA 55.80
175.60
141.50
68.42
218.51
140.55
-3.76
270.24
187.70
56.77
115.59
growth rate 214.7% -19.4% -51.7% 219.4% -35.7% -100.0% 100.0% -30.6% -69.8% 103.6%
FCF per Share 0.46
2.30
3.22
0.33
2.86
2.43
-0.13
1.16
2.96
0.02
1.89
growth rate 400.0% 40.0% -89.8% 766.7% -15.0% -100.0% 100.0% 155.2% -99.3% 9,350.0%
Sale Purchase of Stock -6.95
-10.01
-13.52
1.18
-20.00
-71.03
-5.00
growth rate 0.0% 0.0% 100.0% -100.0% 0.0% 0.0%
FCF 29.00
143.00
202.00
32.00
180.00
80.00
-75.00
233.00
157.00
6.00
50.00
growth rate 393.1% 41.3% -84.2% 462.5% -55.6% -100.0% 100.0% -32.6% -96.2% 733.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 7,243.20
8,037.60
8,123.60
8,627.91
8,868.32
9,071.53
9,440.18
9,772.95
9,723.43
9,318.28
9,838.71
growth rate 11.0% 1.1% 6.2% 2.8% 2.3% 4.1% 3.5% -0.5% -4.2% 5.6%
Op.Income 180.70
201.30
195.90
115.20
109.00
110.88
197.04
227.26
224.27
149.96
109.64
growth rate 11.4% -2.7% -41.2% -5.4% 1.7% 77.7% 15.3% -1.3% -33.1% -26.9%
IBT 164.70
188.20
181.60
189.83
183.36
184.99
126.48
173.21
172.54
57.48
-469.20
growth rate 14.3% -3.5% 4.5% -3.4% 0.9% -31.6% 36.9% -0.4% -66.7% -100.0%
Net Income 93.30
104.70
110.60
115.20
109.00
110.88
66.50
103.41
108.79
72.79
-437.01
growth rate 12.2% 5.6% 4.2% -5.4% 1.7% -40.0% 55.5% 5.2% -33.1% -100.0%
EPS 1.50
1.67
1.75
1.81
1.72
1.76
1.06
1.65
1.76
1.20
-7.28
growth rate 11.3% 4.8% 3.4% -5.0% 2.3% -39.8% 55.7% 6.7% -31.8% -100.0%
Gross Profit 717.30
814.40
807.70
857.54
924.65
1,117.08
1,172.97
1,214.57
1,187.31
1,171.87
1,366.96
growth rate 13.5% -0.8% 6.2% 7.8% 20.8% 5.0% 3.6% -2.2% -1.3% 16.7%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 30.80
38.98
42.29
36.51
8.45
growth rate 26.6% 8.5% -13.7% -76.9%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 758.94
778.16
856.67
870.19
823.42
growth rate 2.5% 10.1% 1.6% -5.4%
Acct.Payable 947.57
958.27
1,067.55
1,107.54
1,109.59
growth rate 1.1% 11.4% 3.8% 0.2%
Cur.Assets 2,181.91
2,187.77
2,515.18
2,492.91
2,538.58
growth rate 0.3% 15.0% -0.9% 1.8%
Total Assets 3,376.29
3,391.55
4,043.13
4,032.28
3,773.79
growth rate 0.5% 19.2% -0.3% -6.4%
Cash 104.52
87.63
118.19
124.89
103.37
growth rate -16.2% 34.9% 5.7% -17.2%
Inventory 990.19
1,021.71
1,220.12
1,203.84
1,290.10
growth rate 3.2% 19.4% -1.3% 7.2%
Cur.Liabilities 1,309.73
1,325.98
1,420.76
1,456.75
1,472.01
growth rate 1.2% 7.2% 2.5% 1.1%
Liabilities 2,360.81
2,372.64
3,240.92
3,239.87
3,255.37
growth rate 0.5% 36.6% 0.0% 0.5%
LT Debt 896.63
897.07
1,669.48
1,640.46
1,641.77
growth rate 0.1% 86.1% -1.7% 0.1%
Equity 1,015.48
1,018.92
802.21
792.41
518.42
growth rate 0.3% -21.3% -1.2% -34.6%
Common Shares 122.95
123.62
124.68
124.54
124.59
growth rate 0.6% 0.9% -0.1% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 9.65
7.07
12.74
12.67
12.38
growth rate -26.7% 80.1% -0.5% -2.3%
Cash Dividends 15.84
16.07
16.21
growth rate 1.5% 0.9%
Cash From OA 51.13
18.27
27.98
76.26
-6.92
growth rate -64.3% 53.1% 172.5% -100.0%
Sale Purchase of Stock
growth rate
FCF 41.48
11.20
15.24
63.58
-19.30
growth rate -73.0% 36.1% 317.3% -100.0%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 2,389.83
2,372.58
2,458.27
2,464.88
2,542.98
growth rate -0.7% 3.6% 0.3% 3.2%
Op.Income 30.80
38.98
42.29
36.51
8.45
growth rate 26.6% 8.5% -13.7% -76.9%
IBT -18.33
13.96
-190.62
-2.47
-290.07
growth rate 100.0% -100.0% 0.0% 0.0%
Net Income 23.00
8.15
-182.78
-0.57
-261.82
growth rate -64.6% -100.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 315.21
324.69
343.05
361.60
364.71
growth rate 3.0% 5.7% 5.4% 0.9%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (13.58)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 15.62 -0.48 4.40
EPS / Growth -0.3% -7.28 6.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 2.00 3.20 3.20
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.